Zimmer Biomet Holdings (ZBH) Net Cash Flow (2009 - 2026)

Zimmer Biomet Holdings' Net Cash Flow history runs 18 years deep, the most recent figure standing at -$168.8 million for Q1 2026.

• In Q1 2026, Net Cash Flow fell 119.81% year-over-year to -$168.8 million; the TTM figure through Mar 2026 stood at -$973.6 million (down 197.74% YoY), while the FY2025 annual figure was $47.4 million, down 62.62% from the prior year.
• Net Cash Flow was -$168.8 million for Q1 2026 at Zimmer Biomet Holdings, up from -$701.6 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $852.2 million in Q1 2025 to a low of -$842.4 million in Q2 2025.
• Historically, Net Cash Flow has averaged $6.1 million across 5 years, with a median of -$17.1 million in 2024.
• Biggest YoY gain for Net Cash Flow was 5083.63% in 2025; the steepest drop was 2861.97% in 2025.
• A 5-year view of Net Cash Flow shows it stood at -$181.7 million in 2022, then soared by 163.95% to $116.2 million in 2023, then sank by 121.94% to -$25.5 million in 2024, then slumped by 2651.37% to -$701.6 million in 2025, then surged by 75.94% to -$168.8 million in 2026.
• The last three Net Cash Flow figures came in at -$168.8 million (Q1 2026), -$701.6 million (Q4 2025), and $739.2 million (Q3 2025), per Business Quant data.